Value Bridge — ST. MARYS MEDICAL CENTER INC.
Current $-50M → Target $-39M (+$11.2M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-50.0M
Current EBITDA
$-38.8M
Target EBITDA
+$11.2M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.5M
Payer Mix Optimization
$6.1M
Cost to Collect Reduction
$2.0M
Clean Claim Improvement
$1.5M
Volume & Rate Growth
$10.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-50M to $-39M. The highest-impact lever is Volume & Rate Growth at $4.1M probability-weighted.
IC talking point: "We see $11M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $123M in equity value creation."